# JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active (JERE) **Source:** https://fundology.uk/fund/jere · ISIN IE00BF4G7183 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 30/09/2026, JERE (Europe Res. Enh. In. Eq. Active, ISIN IE00BF4G7183) closed at £47.34 on the London Stock Exchange. Its ongoing charge is 0.25% a year (about £25 on £10,000). Over the five years to 30/09/2026 its total return was +64.2%, or +28.4% after UK CPIH inflation. ## Summary JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active is an exchange-traded fund (ETF) from JPMorgan, launched in 2018. It tracks the No Underlying Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.25% a year — about £25 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£47.34** (30/09/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | JERE | | ISIN | IE00BF4G7183 | | Category | European shares | | Type | ETF | | Provider | JPMorgan | | Income | Accumulating | | Ongoing charge | 0.25% a year (£25 per £10,000) | | Fund size | £1.8bn | | Launched | 2018 | | Domicile | Ireland | ## Past returns (periods to 30/09/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +17.07% | +13.40% | income reinvested | | 3 years | +49.64% | +35.04% | income reinvested | | 5 years | +64.20% | +28.36% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Calendar-year returns Calendar-year returns of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active in pounds (price, with income reinvested in the fund): 2022 −3.8%, 2023 +14.5%, 2024 +2.2%, 2025 +25.3%; 2026 to 30/09/2026 +8.7%. Returns of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +16.8%; to 30/09/2025: +10.3%; to 30/09/2024: +15.5%; to 30/09/2023: +18.4%; to 30/09/2022: −9.0%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | -3.8% | -11.9% | Price | | 2023 | +14.5% | +9.9% | Price | | 2024 | +2.2% | -1.3% | Price | | 2025 | +25.3% | +21.0% | Price | | 2026 to 30/09/2026 | +8.7% | +5.7% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 13.75% | -11.00% | | 3 years | 12.44% | -11.00% | | 5 years | 13.74% | -14.59% | ## Largest fall Volatility of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active in pounds, annualised from weekly returns to 30/09/2026: 13.7% over 1 year, 12.4% over 3 years, 13.7% over 5 years. Largest fall in the price of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active since October 2021, in pounds: −14.6% from 12/11/2021 to 04/03/2022. The lowest 12-month return of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active in pounds (price, with income reinvested in the fund) since January 2021 was −9.4% (12 months to 14/10/2022); the highest was +29.0% (12 months to 10/04/2026). On 30/09/2026 the price of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active was 3.5% below its highest weekly close since October 2021 (06/08/2026), in pounds. ## Charges compared with similar funds Ongoing charge of JPMorgan ETFs (IE) ICAV - Europe Res. Enh. In. Eq. Active 0.25% a year, as of 01/10/2026: 86 of the 225 other European share funds charge more, 21 the same and 118 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.25%** per year - ISA eligible: yes - SIPP eligible: yes ## Top holdings Largest positions (as of 30/09/2026): | Holding | Weight | |---|---| | ASML Holding NV /Eur/ | 5.69% | | Siemens Ag-Reg /Eur/ | 2.37% | | HSBC Holdings Plc /Gbp/ | 2.35% | | Astrazeneca Plc /Gbp/ | 2.18% | | Shell Plc-New /Gbp/ | 2.14% | | Allianz SE Registered /Eur/ | 2.11% | | Nestle Sa-Reg /Chf/ | 1.97% | | Roche Holding AG /Chf/ | 1.97% | | Banco Santander SA /Eur/ | 1.87% | | Novartis Ag-Reg /Chf/ | 1.85% | ## Where it invests Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed. ### By sector As published by JPMorgan, as of 30/09/2026. | Sector | Weight | |---|---| | Banks | 17.3% | | General Industry | 13.7% | | Health Care | 12.0% | | Consumer Non-Durables | 7.3% | | Technology - Semis & Hardware | 6.5% | | Insurance | 5.8% | | Utilities | 5.2% | | Oil | 4.6% | | Other sectors | 27.6% | ### By country Added up from the holdings JPMorgan publishes, as of 30/09/2026. | Country | Weight | |---|---| | United Kingdom | 23.7% | | France | 16.0% | | Germany | 15.4% | | Switzerland | 12.0% | | Netherlands | 12.0% | | Spain | 5.4% | | Denmark | 3.5% | | Italy | 3.5% | | Other countries | 8.0% | | Not classified | 0.6% | ### By type of asset Added up from the holdings JPMorgan publishes, as of 30/09/2026. | Type of asset | Weight | |---|---| | Equity | 99.5% | | Cash and money market | 0.6% | All 154 holdings: https://fundology.uk/fund/jere/holdings --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.